[ad_1]
Germany has to relax very quickly when it comes to vaccination
Is there now AstraZeneca for everyone?
The AstraZeneca vaccine could be distributed to anyone who wants it. At least that’s what various country leaders suggest. Therefore, the vaccination rate should be accelerated. The fourth vaccine is now on the run in the United States.
The imminent vaccine glut calls for a quick rethink of policy. The above rules should be relaxed or removed. This is the only way to inoculate millions of additional doses. The month can be a great opportunity.
WITHTarget and half a million doses of corona vaccines were stored in Germany on Friday, another million doses had been announced for the weekend and more than 900,000 doses are expected for Monday and Tuesday. In other words, Germany is currently facing an excess of vaccines.
You can already guess what is coming: a situation that was actually predictable caught politics and administration on the wrong foot. The German community has already been tolerably overwhelmed: even with moderate amounts of administration, millions of doses of vaccines remained for far too long, without a trace of the “just-in-time” logistics principle common in the private sector.
This may be due to a lesser extent to the fact that frightened citizens reject AstraZeneca’s (undoubtedly effective) vaccine, but only to a lesser extent. Now it is even more important to quickly rethink the entire vaccination campaign.
Because at the possible start of a third wave of mutation-driven infections, priority cannot be given in case of doubt, only the total exhaustion of vaccination potential. In other words, in the actual conditions that sadly exist: better messy, but fast, than orderly in a dangerous slow-motion pace.
No one benefits from a vial of vaccine that in theory would go to the right person, but in practice it is left wasted on the refrigerated shelf.
So now we need a taboo-free debate. Releasing unused AstraZeneca cans for everyone, as Bavaria and Baden-Württemberg want, is a real possibility. But only a first step.
Five million doses of the Biontech vaccine, for example, will be delivered over the course of March, without a quick relaxation of the rules, the backlog threatening to be even higher here too.
The rapid involvement of family and company doctors in the vaccination campaign would also push capabilities to new dimensions. Then there would also be the possibility, with the Biontech and Moderna vaccines, to distance yourself from the unfortunate idea of giving two vaccines to a few people instead of many with at least one (which alone offers considerable protection).
Ideally, March could be the month that Germany pulls nearly ten million more of its citizens out of the pandemic race with a jab, and politics regains much of the trust that has been lost for months. But it can also be quite different.
“All in Stock” is the daily stock market shot by WELT’s business editorial team. Every morning from 7am with financial journalists Moritz Seyffarth and Holger Zschäpitz. For stock exchange experts and beginners. Subscribe to the podcast on Spotify, Apple Podcast, Amazon Music, and Deezer. Or directly through RSS.
